BPI chief prepares for Philippine equity uptick

Cezar “Bong” Consing, recently appointed president and chief executive of Bank of the Philippine Islands, wants to get involved in an emerging ECM and M&A story.
Cezar Consing argues the question is whether the Philippines’ internal strengths will be enough to ride out the coming tightening of global liquidity once the US Federal Reserve begins to reduce or end its quantitative easing program.
Cezar Consing argues the question is whether the Philippines’ internal strengths will be enough to ride out the coming tightening of global liquidity once the US Federal Reserve begins to reduce or end its quantitative easing program.

Cezar Consing, president and chief executive of Bank of the Philippine Islands BPI, aims to help the group become a relevant player in equities and MA. “With more long-term capital formation taking place, we need to pay more attention to MA and equity capital markets,” he says in an interview with FinanceAsia.

Consing, who joined the bank at the start of the year and is known by his nickname Bong, expects more companies to go public. Most listed conglomerates are controlled outright by families, posing liquidity challenges for investors, but he thinks some will allow a greater free float.

Although he is...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222